4//SEC Filing
Shearman Mark S 4
Accession 0001415889-23-002604
CIK 0001650664other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:30 PM ET
Size
4.9 KB
Accession
0001415889-23-002604
Insider Transaction Report
Form 4
Shearman Mark S
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-02-13$9.67/sh−2,790$26,966→ 65,559 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 19, 2021 and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 10, 2023. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001643799
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:30 PM ET
- Size
- 4.9 KB